Owen Hughes
CIK 1575933 · Chief Executive Officer · last filed 2026-07-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.63M
Companies
9
Total Filings
43
Lifetime Open-Market Net
$111.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XOMA | Chief Executive Officer | 0 | $40.17 | $0 | $0 | 1 | 2026-07-14 |
| CCCC | Director | — | $3.55 | — | $0 | 4 | 2026-06-26 |
| ANAB | Director | — | $52.11 | — | $0 | 1 | 2026-05-13 |
| XOMAP | Chief Executive Officer | 191,559 | $24.98 | $4.79M | $1.30M | 11 | 2026-04-22 |
| ImageneBio, Inc. (IKNA) Delisted | Director | — | $17.16 | — | $0 | 3 | 2024-06-10 |
| Radius Health, Inc. (RDUS) Delisted | Director | 0 | $30.00 | $0 | -$102.7K | 15 | 2022-08-15 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | 30,000 | $2.16 | $64.8K | $0 | 2 | 2021-12-30 |
| Translate Bio, Inc. (TBIO) Delisted | Director | 0 | $0.00 | $0 | -$1.13M | 4 | 2021-09-14 |
| CGEM | President and CEO | 506,226 | $17.47 | $8.84M | $52.5K | 2 | 2021-01-14 |
Recent Filings · Page 2 of 5
43 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-21 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-10 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2023-11-20 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2023-10-04 | XOMAP | Buy (P) | +1,000 | $13.8K | EDGAR |
| 2023-09-27 | XOMAP | Buy (P) | +2,500 | $36.1K | EDGAR |
| 2023-06-13 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | XOMAP | Buy (P) | +2,000 | $47.3K | EDGAR |
| 2023-01-05 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2022-12-19 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.